Extended-release hydrocodone (Hysingla ER) for pain.
Hysingla ER, the second single-ingredient extended-release hydrocodone product to become available in the US, is formulated for once-daily use. Zohydro ER is dosed twice daily and costs more. Both Hysingla ER and the new formulation of Zohydro ER have abuse-deterrent properties, but they will still be subject to misuse.
D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000737:chemistry; D000818:Animals; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000737:chemistry; D006801:Humans; D006853:Hydrocodone / Q000008:administration & dosage* / Q000737:chemistry; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000379:methods
D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D006853:Hydrocodone